The Syrian actor, Yahya Bayazi, has elicited a state of sympathy and support on social media, especially in the artistic community, after appearing on a live broadcast with his colleague, actor Wael Sharaf, in delicate health and with difficulty speaking.
Piazzi, however, did not confirm the nature of his illness average Arabic, includingETIn Arabic, he indicated that he had multiple sclerosis, which raised questions about the nature of this disease, its symptoms and methods of treatment.
What is Multiple Sclerosis?
The disease is also known as “multiple sclerosis” (MS), and is an unpredictable disease affecting the central nervous system, where communication between the brain and other parts of the body is disrupted, according to “Aat the National Institute of Neurological Disorders and Strokein the United States.
Many researchers believe that MS is an autoimmune disease, in which the body, through its immune system, launches a defensive attack against its own tissues, according to the institute.
In MS, the immune system attacks the myelin that coats nerve fibers in the human body, and these attacks may be related to an unknown environmental trigger, perhaps a virus.
Professor of neurology and multiple sclerosis at Ain Shams University, Dr. Iman Al-Marakibi talks about “an immune disease that causes a defect in the transmission of orders from the human brain to the muscles,” which causes a problem in the patient’s body.
In his interview with the site “Al-Hurra”, he points out that “the repercussions of the disease depend on where the immune inflammation occurs, and if this occurs in the place responsible for movement in the human brain, the weakness of movement can reach paralysis.”
And if the inflammation affects the optic nerve, the patient suffers from vision problems, and if this happens with the “cerebellum”, the patient will suffer from an imbalance, according to his speech.
Symptoms of the disease?
Most people experience the first symptoms of MS in their 20s and 40s, often as “blurred or double vision, distorted red and green coloring, or even blindness in one eye,” according to the institute.
Most patients with multiple sclerosis experience muscle weakness in their limbs and difficulty with coordination and balance, and these symptoms can be severe enough to prevent them from walking or even standing, according to the institute.
The signs and symptoms of multiple sclerosis vary widely and depend on the amount of nerve damage and which nerves are affected.Mayo Clinic“.
Some people with severe multiple sclerosis may lose the ability to walk permanently, while others may go through long periods of lethargy with no new symptoms, according to the Mayo Clinic.
The disease can cause permanent nerve damage or deterioration, according to the Mayo Clinic website.
In the worst cases, MS can lead to partial or complete paralysis, according to the National Institute of Neurological Disorders and Stroke.
Causes of disease?
Dr. Iman Al-Marakibi lists the causes of multiple sclerosis, including hereditary factors such as one of the family members suffering from the disease and other genetic and environmental factors.
As for the environmental factors, they are “lack of vitamin D in the body, smoking, lack of regular exercise, viral infections that the body copes with incorrectly, and obesity,” according to al-Marakibi’s speech.
Women are more susceptible to the disease than men by a ratio of 3 to 1 due to hormones, according to al-Marakibi’s statement.
Is there a cure for the disease?
Until now, there is no treatment that completely cures multiple sclerosis, but treatments can help speed recovery from attacks, change the course of the disease, and treat symptoms, according to the Mayo Clinic.
Al-Marakibi points out that the disease is “chronic” and can be mitigated by continuing treatment continuously, and can be lifelong, and if the patient does not comply with this, he may suffer a “relapse”.
He stresses that there is no “definitive cure for the disease”, but at the same time indicates that “there are recent studies on the possibility of interrupting the patient’s treatment if his condition improves and there are no relapses and infections”.